HTA Programme

Selecting Criteria

Health Technology Assessment: Aligning criteria and identifying goals

In response to a request from our membership and with guidance from an industry Task Force, CIRS has developed a programme that will address the increasing impact of HTA and payer activities on drug development, regulation and patient access to innovative medicines. Key programme goals are to advance HTA/payer and regulatory agency interaction in terms of scientific advice and alignment of technical requirements; improve the understanding of HTA/payer processes and decision making; and promote best practice by the application of tools developed by CIRS over the past 30 years.

The key activities for the HTA Programme include:

Workshops: following the successful CIRS model of bringing agency and industry stakeholders together, the programme will focus on issues related to improving predictability, transparency and decision making
Systematic Process Maps across countries will be developed to enable the comparison and understanding of how evidence moves from registration to reimbursement
Benchmarking: benchmarking of time and process will be developed based on company- and agency-provided data in order to enable comparison between systems and to identify trends
Industry and Agency meetings